Assessment of a HER2 scoring system for colorectal cancer: results from a validation study | Modern Pathology
The HER family as therapeutic targets in colorectal cancer - ScienceDirect
Prevalence, prognosis and predictive status of HER2 amplification in anti-EGFR-resistant metastatic colorectal cancer | Clinical and Translational Oncology
Detecting HER2 Amplification in Colorectal Cancer
Targeting the Tumor in Colorectal Cancer – Where do we Stand with Precision Medicine in 2020 | Published in healthbook TIMES Oncology Hematology
Combined targeting of HER-2 and HER-3 represents a promising therapeutic strategy in colorectal cancer | BMC Cancer | Full Text
PDF) HER2 Activating Mutations Are Targets for Colorectal Cancer Treatment | Simonetta Leto - Academia.edu
Dual HER2 Blockade in Patients With HER2-Amplified Metastatic
HER2 overexpression/amplification status in colorectal cancer: a comparison between immunohistochemistry and fluorescence in situ hybridization using five different immunohistochemical scoring criteria | Journal of Cancer Research and Clinical Oncology
HER2 Biomarker in Colon Cancer | Know Your Biomarker
Hitting the Target in HER2-Positive Metastatic Colorectal Cancer | PPT
Targeting the human epidermal growth factor receptor 2 (HER2) oncogene in colorectal cancer - ScienceDirect
Frontiers | Remarkable Response of EGFR- and HER2-Amplified Metastatic Colon Cancer to Pyrotinib After Failed Multiline Treatments: A Case Report and Literature Review
Frontiers | Human Epidermal Growth Factor Receptor 2 Overexpression and Amplification in Patients With Colorectal Cancer: A Large-Scale Retrospective Study in Chinese Population
![en]HER2 Therapies for Patients with mCRC[:fr]Les thérapies HER2 pour les patients atteints de mCCR[:] - Colorectal Cancer Canada](https://www.colorectalcancercanada.com/wp-content/uploads/2023/08/her2receptor.png "en]HER2 Therapies for Patients with mCRC[:fr]Les thérapies HER2 pour les patients atteints de mCCR[:] - Colorectal Cancer Canada")
en]HER2 Therapies for Patients with mCRC[:fr]Les thérapies HER2 pour les patients atteints de mCCR[:] - Colorectal Cancer Canada
HER2 evaluation by immunohistochemistry and fluorescence in situ... | Download Scientific Diagram
EGFR, HER2, and HER3 protein expression in paired primary tumor and lymph node metastasis of colorectal cancer | Scientific Reports
![Somatic mutation profiling, tumor-infiltrating leukocytes, tertiary lymphoid structures and PD-L1 protein expression in HER2-amplified colorectal cancer [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2023/15261/1/fig-2-full.png "Somatic mutation profiling, tumor-infiltrating leukocytes, tertiary lymphoid structures and PD-L1 protein expression in HER2-amplified colorectal cancer [PeerJ]")
Somatic mutation profiling, tumor-infiltrating leukocytes, tertiary lymphoid structures and PD-L1 protein expression in HER2-amplified colorectal cancer [PeerJ]
Cancers | Free Full-Text | Emerging Role of ERBB2 in Targeted Therapy for Metastatic Colorectal Cancer: Signaling Pathways to Therapeutic Strategies
Comprehensive assessment of HER2 alteration in a colorectal cancer coh | CMAR
IJMS | Free Full-Text | Beyond RAS and BRAF: HER2, a New Actionable Oncotarget in Advanced Colorectal Cancer
HER2 Status in Colorectal Cancer: Its Clinical Significance and the Relationship between HER2 Gene Amplification and Expression | PLOS ONE
The predictive role of ERBB2 point mutations in metastatic colorectal cancer: A systematic review - ScienceDirect
Life | Free Full-Text | HER2 in Metastatic Colorectal Cancer: Pathology, Somatic Alterations, and Perspectives for Novel Therapeutic Schemes
![HER2 and BRAF mutation in colorectal cancer patients: a retrospective study in Eastern China [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2020/8602/1/fig-1-full.png "HER2 and BRAF mutation in colorectal cancer patients: a retrospective study in Eastern China [PeerJ]")
HER2 and BRAF mutation in colorectal cancer patients: a retrospective study in Eastern China [PeerJ]
